Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Vyvanse lisdexamfetamine dimesylate salt form?

See the DrugPatentWatch profile for Vyvanse

Lisdexamfetamine dimesylate is the active salt form of Vyvanse, a medication used to treat attention deficit hyperactivity disorder (ADHD) and binge eating disorder [1]. The dimesylate salt designation refers to the specific chemical form of the drug that allows for its extended-release properties [2].

How does the dimesylate salt form contribute to Vyvanse's effectiveness?


The lisdexamfetamine dimesylate salt is a prodrug, meaning it is inactive until it is metabolized in the body [3]. After oral administration, the dimesylate salt is hydrolyzed in the gastrointestinal tract and then in the blood, releasing dextroamphetamine and L-lysine [4]. This enzymatic conversion process is what enables the slow and sustained release of dextroamphetamine throughout the day, contributing to Vyvanse's long-acting therapeutic effect [3][4].

When does the patent for Vyvanse expire?


The primary patents for Vyvanse have faced numerous challenges and expirations. For instance, a key patent was invalidated by the U.S. Patent and Trademark Office in 2020 [5]. While the exact expiry dates for all related patents can be complex and subject to litigation, generic versions of lisdexamfetamine dimesylate have become available [5][6]. For detailed and up-to-date patent information, DrugPatentWatch.com is a valuable resource [7].

What are the implications of patent expiry for Vyvanse?


Patent expiry typically opens the door for the introduction of generic alternatives to a branded drug. This can lead to increased competition and potentially lower prices for consumers [5][6]. The availability of generic lisdexamfetamine dimesylate has already begun to impact the market for ADHD treatment [6].

Are there other formulations or medications for ADHD?


Yes, there are various stimulant and non-stimulant medications available for ADHD treatment. Stimulants, like dextroamphetamine (the active component of Vyvanse) and methylphenidate, are common first-line treatments. Non-stimulant options include medications such as atomoxetine, guanfacine, and clonidine [8]. These medications work through different mechanisms to manage ADHD symptoms.



Other Questions About Vyvanse :

vyvanse generi vyvanse medication class generic name of vyvanse generic vyvanse cost how much is brand name vyvanse Alternatives to Vyvanse? Why is vyvanse generic so expensive?